E-selectin binding peptide–polymer–drug conjugates and their selective cytotoxicity against vascular endothelial cells
Authors:
- Denise PaulinDPDenise Paulin
- Gonen AshkenasyGAGonen Ashkenasy
- Ayelet DavidADAyelet David
- 1 November 2009
- journal article
- Published by Elsevier in Biomaterials
- Vol. 30 (32) , 6460-6468
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Biorecognition and Subcellular Trafficking of HPMA Copolymer−Anti-PSMA Antibody Conjugates by Prostate Cancer CellsMolecular Pharmaceutics, 2009
- HPMA as a Scaffold for the Modular Assembly of Functional Peptide Polymers by Native Chemical LigationBioconjugate Chemistry, 2008
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Targeting selectins and selectin ligands in inflammation and cancerExpert Opinion on Therapeutic Targets, 2007
- Polymeric conjugates of mono- and bi-cyclic αVβ3 binding peptides for tumor targetingJournal of Controlled Release, 2006
- Targeting tumor angiogenic vasculature using polymer–RGD conjugatesJournal of Controlled Release, 2005
- Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and InhibitorsAngewandte Chemie International Edition, 1998
- Phage DisplayChemical Reviews, 1997
- Peptides Which Bind to E-selectin and Block Neutrophil AdhesionJournal of Biological Chemistry, 1995
- Filamentous Fusion Phage: Novel Expression Vectors That Display Cloned Antigens on the Virion SurfaceScience, 1985